Lipid-Based Nanocarriers: Redefining Polyphenol Delivery in OcularTherapeutics

Introduction: Polyphenols and plant-derived compounds are known for their antioxidant and anti-inflammatory properties, making them promising agents for treating ocular diseases such as cataracts, glaucoma, age-related macular degeneration, and dry eye syndrome. However, their clinical utility is limited by poor solubility, low bioavailability, and instability. The reviews aim to highlight the potential of lipid-based nanocarriers to enhance the ocular delivery of polyphenols by overcoming physiological and physicochemical limitations. Methods: A comprehensive literature review was conducted on various lipid-based nanocarriers, including solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), Liposomes, Micelles, Cubosomes, nanoemulsions, niosomes, and Transferosomes. The article discusses formulation strategies, surface modifications, characterization techniques, in vitro and in vivo evaluations, and pharmacokinetics studies. Results: Lipid-based nanocarriers improve polyphenol solubility, stability, corneal penetration, ocular retention, and sustained drug release. Surface modification with chitosan, hyaluronic acid, and other bioadhesive polymers enhanced mucoadhesion and targeting. Studies confirmed increased bioavailability, extended residence time, and reduced inflammation in animal models. Encapsulation efficiencies ranged from 60-98% with particle sizes typically below 200nm. Pharmacokinetic studies showed up to 4-6-fold improvement in area under the curve (AUC) and drug residence time over conventional formulations. Discussion: Lipid-based nanocarriers improve polyphenol solubility, stability, corneal penetration, ocular retention, and sustained drug release. Surface modification with chitosan, hyaluronic acid, and other bioadhesive polymers enhanced mucoadhesion and targeting. Conclusion: Lipid-based nanocarriers offer a promising platform for ocular delivery of polyphenols. They improve therapeutic outcomes b

Authors

Institutions

Publication Details

Journal
Current Nanomedicine
Published
2026-03-16
DOI
https://doi.org/10.2174/0124681873400110251129180814
Primary Topic
Advanced Drug Delivery Systems
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Lipid-Based Nanocarriers: Redefining Polyphenol Delivery in OcularTherapeutics

Rashmi Mallya, Janhavi Panchal, Shikha Dubey
Current Nanomedicine
Advanced Drug Delivery Systems
article

Lipid-Based Nanocarriers: Redefining Polyphenol Delivery in OcularTherapeutics

Rashmi Mallya, Janhavi Panchal, Shikha Dubey
article en

Abstract

Introduction: Polyphenols and plant-derived compounds are known for their antioxidant and anti-inflammatory properties, making them promising agents for treating ocular diseases such as cataracts, glaucoma, age-related macular degeneration, and dry eye syndrome. However, their clinical utility is limited by poor solubility, low bioavailability, and instability. The reviews aim to highlight the potential of lipid-based nanocarriers to enhance the ocular delivery of polyphenols by overcoming physiological and physicochemical limitations. Methods: A comprehensive literature review was conducted on various lipid-based nanocarriers, including solid lipid nanoparticles (SLNs), nanostructured lipid carriers (NLCs), Liposomes, Micelles, Cubosomes, nanoemulsions, niosomes, and Transferosomes. The article discusses formulation strategies, surface modifications, characterization techniques, in vitro and in vivo evaluations, and pharmacokinetics studies. Results: Lipid-based nanocarriers improve polyphenol solubility, stability, corneal penetration, ocular retention, and sustained drug release. Surface modification with chitosan, hyaluronic acid, and other bioadhesive polymers enhanced mucoadhesion and targeting. Studies confirmed increased bioavailability, extended residence time, and reduced inflammation in animal models. Encapsulation efficiencies ranged from 60-98% with particle sizes typically below 200nm. Pharmacokinetic studies showed up to 4-6-fold improvement in area under the curve (AUC) and drug residence time over conventional formulations. Discussion: Lipid-based nanocarriers improve polyphenol solubility, stability, corneal penetration, ocular retention, and sustained drug release. Surface modification with chitosan, hyaluronic acid, and other bioadhesive polymers enhanced mucoadhesion and targeting. Conclusion: Lipid-based nanocarriers offer a promising platform for ocular delivery of polyphenols. They improve therapeutic outcomes b

Current NanomedicineVol. 16
Shri Vile Parle Kelavani Mandal (IN)
Openalex Percentile: Top 13%
Advanced Drug Delivery Systems
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.